Cargando…
Modification effect of fenofibrate therapy, a longitudinal epigenomic-wide methylation study of triglycerides levels in the GOLDN study
BACKGROUND: Identification of interactions between epigenetic factors and treatments might lead to personalized intervention of diseases. This paper aims to examine the modification effect of fenofibrate therapy on the association of methylation levels and fasting blood triglycerides (TG), and the r...
Autores principales: | Wei, Runmin, Wu, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157287/ https://www.ncbi.nlm.nih.gov/pubmed/30255776 http://dx.doi.org/10.1186/s12863-018-0643-6 |
Ejemplares similares
-
Family-based genome-wide association of inflammation biomarkers and fenofibrate treatment response in the GOLDN study
por: Das, Sarmistha, et al.
Publicado: (2018) -
The PPAR Alpha gene is associated with triglyceride, low-density cholesterol, and inflammation marker response to fenofibrate intervention: The GOLDN Study
por: Frazier-Wood, A.C., et al.
Publicado: (2012) -
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Assessment of fenofibrate-methylation interactions on triglycerides using longitudinal family data
por: Yu, Jih-Chang, et al.
Publicado: (2018) -
Integrating epigenetic, genetic, and phenotypic data to uncover gene-region associations with triglycerides in the GOLDN study
por: Romanescu, Razvan G., et al.
Publicado: (2018)